OTC: LABFF - Laboratorios Farmaceuticos Rovi, S.A.

Rentabilité sur six mois: 0%
Secteur: Healthcare

Calendrier des promotions Laboratorios Farmaceuticos Rovi, S.A.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company distributes other products that are licensed from other laboratories. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa.

plus de détails
It provides non-prescription pharmaceutical products; and contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, hard capsules, and sachets. The company was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

EBITDA 0.0546
EV/EBITDA 0.2831
Industry Biotechnology
P/BV 7.28
P/E 44.56
P/S 6.48
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 0.3414
Див.доход ао 3.96
Дивиденд ао 2.11
Сайт https://www.rovi.es
Цена ао 86.05
Число акций ао 0.05319 млрд
Changement de prix par jour: 0% (90.61)
Changement de prix par semaine: 0% (90.61)
Changement de prix par mois: 0% (90.61)
Changement de prix sur 3 mois: 0% (90.61)
Changement de prix sur six mois: 0% (90.61)
Changement de prix par an: +74.25% (52)
Evolution du prix sur 3 ans: +31.8% (68.75)
Evolution du prix sur 5 ans: 0% (90.61)
Evolution des prix sur 10 ans: 0% (90.61)
Evolution des prix depuis le début de l'année: 0% (90.61)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 3.02 5
P/BV 5.09 3
P/E 14.7 8
EV/EBITDA 10.35 7
Total: 5.88

Efficacité

Nom Signification Grade
ROA, % 23.55 7
ROE, % 34.92 9
Total: 6.83

Dividendes

Nom Signification Grade
Div yield, % 3.96 9.9
DSI 0.9 9
Total: 6.56

Devoir

Nom Signification Grade
Debt/EBITDA 0.1905 10
Total: 10

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 136.19 10
Rentabilité Ebitda, % 337.35 10
Rentabilité EPS, % 388.3 10
Total: 8
Plus de détails

Établissements Volume Partager, %
Price (T.Rowe) International Discovery Fund 830932 1.54
Vanguard International Stock Index-Total Intl Stock Indx 281370 0.52
Victory Portfolios-Victory Trivalent International Small Cap Fund 222468 0.41
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund 169903 0.31
Price (T.Rowe) International Small-Cap Equity Trust 134631 0.25
iShares Core MSCI EAFE ETF 114899 0.21
DFA Continental Small Company Series 113531 0.21
DFA International Core Equity Portfolio 104540 0.19
iShares MSCI EAFE Small Cap ETF 91619 0.17
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index 83291 0.15



Superviseur Titre d'emploi Paiement Année de naissance
Mr. Juan Lopez-Belmonte Encina Chairman & CEO 1.25M
Mr. Ivan Lopez-Belmonte Encina Second Deputy Chairman & GM of Commercial and Development 505.46k
Mr. Javier Lopez-Belmonte Encina First Deputy Chairman, GM of Industrial Operations & CFO 507.61k
Marta Campos Martínez Head of Investor Relations N/A
Ms. Mercedes Benítez del Castillo Sánchez Legal Department Manager N/A
Ms. Rosario Perucha Pérez Marketing Manager N/A
Mr. Francisco Javier Angulo García Human Resources Manager N/A
Mr. Gabriel Nunez Fernandez Secretary N/A
Ms. Beatriz Ávila Alcalde Sales Manager N/A

Adresse: Spain, Madrid, Calle José Isbert. 2 - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.rovi.es